UPDATE : Friday, October 18, 2019
상단여백
Celltrion gets orders for Herzuma in France by Lee Han-soo 2018-11-02 17:08
Government to help Pharmicell develop therapy for acute kidney injury by Lee Han-soo 2018-11-02 14:16
SLS Bio registers patent for nanotechnology multiplex diagnostic in Europe by Lee Han-soo 2018-11-01 11:03
CrystalGenomics to change molecular targeted therapy from injection to oral drug in trials by Nam Doo-hyun 2018-10-30 10:52
‘I will help make Korea original holder of anticancer drugs’ by So Jae-hyeon 2018-10-29 14:43
라인
‘Bio Solution’s value to rise on arthritis cell therapy’ by Nam Doo-hyun 2018-10-25 16:30
Samsung BioLogics posts ₩101.1 billion in Q3 sales by Lee Han-soo 2018-10-25 11:02
CancerRop advances into Malaysian gene market by Lee Han-soo 2018-10-24 17:49
Celltrion releases clinical trial results for Remsima SC in EU and US by Lee Han-soo 2018-10-24 16:47
Will synthetic biology be vital in smart therapeutics? by Nam Doo-hyun 2018-10-24 16:40
라인
Biotech shares tank amid nosediving of Seoul stocks by Nam Doo-hyun 2018-10-24 11:35
‘Antibody drug developer AbClon noteworthy’ by Nam Doo-hyun 2018-10-22 14:49
L&C BIO sets offering price at ₩24,000 for KOSDAQ debut by So Jae-hyeon 2018-10-22 14:12
'Superbug' fears bring antibiotics developers under spotlight by Nam Doo-hyun 2018-10-22 11:53
Celltrion, Samsung BioLogics named Fortune’s ‘Future 50’ by Lee Han-soo 2018-10-19 16:34
라인
CancerRop launches unit to develop cell therapies by Lee Han-soo 2018-10-18 15:25
Biogen, Samsung Bioepis announce European launch of Imraldi by Lee Han-soo 2018-10-17 17:28
Bio stocks listed under ‘tech exception policy’ perform better by Nam Doo-hyun 2018-10-15 12:27
Merck to supply Samsung’s biosimilar to US Veterans Affairs Dept. by Lee Han-soo 2018-10-11 16:31
US drug advisory recommends Celltrion’s Rituxan biosimilar for approval by Lee Han-soo 2018-10-11 12:10
여백
여백
여백
Back to Top